Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Seatle products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Kasur · Pakistan

Punjab-based pharmaceutical manufacturer operating under a DRAP drug manufacturing licence and represented in Pakistan pharmaceutical product data.

Seatle products in Pakistan

Seatle Private Limited has 37 medicine presentations registered in Pakistan under 14 brands, covering 14 generic medicines. Most of its products are in Anti-infectives and Dermatology. Its brands with the most registered strengths and packs are Orpase (Cefixime), Fratazid (Ceftriaxone), CYGNET (Ciprofloxacin) and Terbin (Terbinafine). 37 products have an official DRAP price on MedInfoBase. See all 14 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date22 Jul 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Seatle (Private) Limited
Company type
Private pharmaceutical manufacturer
Address
45-KM, Multan Road, Manga Mandi, District Kasur, Punjab, Pakistan
Phone
+92 49 4540392
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000481 Seatle (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000481 37 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx38public portfolio records represented
REG31unique registrations represented
IDX37indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+1registry-only registrations
VER3registry-verified exact registrations
PKR37current validated price records
G14generic molecules in indexed catalogue
DF7dosage-form groups
TA2therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage97%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSeatle Private LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/seatle-private-limitedGenerated 11 Nov 2026Anti-infectives35 · 95%Dermatology2 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSeatle Private LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/seatle-private-limitedGenerated 11 Nov 202637presentationsTablet14 · 38%Cream6 · 16%Injection6 · 16%Suspension5 · 14%Capsule3 · 8%Lotion2 · 5%Other forms1 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSeatle Private LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/seatle-private-limitedGenerated 11 Nov 202636comparable productsBelow peer median8 · 22%Near peer median13 · 36%Above peer median15 · 42%Company median price position+4.6%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSeatle Private LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/seatle-private-limitedGenerated 11 Nov 2026Valor Pharmaceuticals13 shared93% overlapAtco Laboratories Limited12 shared86% overlapPearl Pharmaceuticals12 shared86% overlapCCL Pharmaceuticals (Pvt.) Limited11 shared79% overlapGlobal Pharmaceuticals (Pvt.) Ltd.11 shared79% overlapEpharm Laboratories11 shared79% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives35 products · 95%
Dermatology2 products · 5%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins15 products · 41%
Antifungals6 products · 16%
Fluoroquinolone antibacterials6 products · 16%
Antiparasitic medicines4 products · 11%
Tetracycline antibacterials2 products · 5%
Macrolide antibacterials2 products · 5%
Retinoids / anti-acne medicines1 products · 3%
Topical corticosteroids / anti-inflammatory dermatologics1 products · 3%
Formulation footprint

Dosage forms

Tablet14 products
Cream6 products
Injection6 products
Suspension5 products
Capsule3 products
Lotion2 products
Gel1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 OrpaseCefixime 9presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Tablet, Capsule #2 FratazidCeftriaxone 6presentations 1 g, 1000 mg, 250 mg, 500 mg · Injection #3 CYGNETCiprofloxacin 3presentations 250 mg, 500 mg, 750 mg · Tablet #4 TerbinTerbinafine 3presentations 1 %, 1% · Cream, Gel #5 AquazoleClotrimazole + Hydrocortisone 2presentations 1 % + 1 %, 1% + 1% · Cream #6 DowquinLevofloxacin 2presentations 250 mg, 500 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Seatle Private Limited is priced against the market

36 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Valor Pharmaceuticals218 products · 96 generics 13shared generics Atco Laboratories Limited275 products · 92 generics 12shared generics Pearl Pharmaceuticals118 products · 46 generics 12shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers30Distinct registrations among indexed, published, presentation-validated products only
Verified price observations37
Products with a verified price37
Products with multiple price observations0
Source records with multiple versions37
Latest portfolio source check9 Aug 2026
Latest effective price date22 Jul 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

31 unique registration(s) · 37 indexed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Aquazole Clotrimazole + Hydrocortisone 1% + 1% Cream 10gm 067931 PKR 152.47 PKR 15.25/g 🔒 Pharma Pro
Aquazole Clotrimazole + Hydrocortisone 1 % + 1 % Cream 20gm 067931 PKR 271.62 PKR 13.58/g 🔒 Pharma Pro
Benzex Benzoyl peroxide 4% Cream 40gm 067936 PKR 250.91 PKR 6.27/g 🔒 Pharma Pro
Betamet Betamethasone valerate 1 mg Lotion 60ml 067930 PKR 179.20 PKR 2.99/mL No comparator
Clobicare CreamRegistry verified Clobetasol propionate — — — 067938Official source ↗ No indexed price — —
CYGNET Ciprofloxacin 500 mg Tablet 1x10's 097420 PKR 345.23 PKR 34.52/tablet 🔒 Pharma Pro
CYGNET Ciprofloxacin 250 mg Tablet 10's 100831 PKR 208.74 PKR 20.87/tablet 🔒 Pharma Pro
CYGNET Ciprofloxacin 750 mg Tablet 10's 100832 PKR 369.31 PKR 36.93/tablet 🔒 Pharma Pro
Dowquin Levofloxacin 250 mg Tablet 10's 097406 PKR 401.43 PKR 40.14/tablet 🔒 Pharma Pro
Dowquin Levofloxacin 500 mg Tablet 10's 097407 PKR 667.98 PKR 66.80/tablet 🔒 Pharma Pro
Doxybact Doxycycline 100 mg Tablet 50's 037104 PKR 478.73 PKR 9.57/tablet 🔒 Pharma Pro
Doxybact Doxycycline 100 mg Tablet 30's 037104 PKR 247.84 PKR 8.26/tablet 🔒 Pharma Pro
Flozex Fluconazole 150 mg Capsule 1's 067929 PKR 351.12 PKR 351.12/capsule 🔒 Pharma Pro
Fratazid Ceftriaxone 250 mg IV injection 1's 084460 PKR 205.66 PKR 205.66/vial/unit 🔒 Pharma Pro
Fratazid Ceftriaxone 250 mg Injection 1's 084463 PKR 205.66 PKR 205.66/vial/unit 🔒 Pharma Pro
Fratazid Ceftriaxone 1000 mg Injection 1's 084464 PKR 653.64 PKR 653.64/vial/unit 🔒 Pharma Pro
Fratazid Ceftriaxone 1 g Injection 1's 115713 PKR 662.95 PKR 662.95/vial/unit 🔒 Pharma Pro
Fratazid Ceftriaxone 500 mg Injection 1's 115714 PKR 351.12 PKR 351.12/vial/unit 🔒 Pharma Pro
Fratazid Ceftriaxone 500 mg Injection 1's 115715 PKR 351.12 PKR 351.12/vial/unit 🔒 Pharma Pro
Moxidow Moxifloxacin 400 mg Tablet 5's 097422 PKR 762.72 PKR 152.54/tablet 🔒 Pharma Pro
Orpase Cefixime 400 mg Capsule 5's 032495 PKR 592.03 PKR 118.41/capsule 🔒 Pharma Pro
Orpase Cefixime 100 mg/5 mL Suspension 60ml 032496 PKR 653.66 PKR 10.89/mL 🔒 Pharma Pro
Orpase Cefixime 100 mg/5 mL Suspension 30ml 032496 PKR 337.31 PKR 11.24/mL 🔒 Pharma Pro
Orpase Cefixime 200 mg/5 mL Suspension 30ml 032497 PKR 424.37 PKR 14.15/mL 🔒 Pharma Pro
Orpase Cefixime 200 mg Capsule 5's 046372 PKR 351.91 PKR 70.38/capsule 🔒 Pharma Pro
Orpase Cefixime 400 mg Tablet 5's 047748 PKR 693.14 PKR 138.63/tablet 🔒 Pharma Pro
Orpase Cefixime 400 mg Tablet 10's 047748 PKR 1,318.03 PKR 131.80/tablet 🔒 Pharma Pro
Orpase Cefixime 200 mg Tablet 5's 047749 PKR 351.91 PKR 70.38/tablet 🔒 Pharma Pro
Orpase Cefixime 200 mg Tablet 10's 047749 PKR 669.68 PKR 66.97/tablet 🔒 Pharma Pro
Orzit Azithromycin 200 mg/5 mL Suspension 30ml 057295 PKR 677.14 PKR 22.57/mL 🔒 Pharma Pro
Orzit Azithromycin 200 mg/5 mL Suspension 15ml 057295 PKR 345.49 PKR 23.03/mL 🔒 Pharma Pro
Scabi-Mect Ivermectin 6 mg Tablet 10's 064839 PKR 565.18 PKR 56.52/tablet 🔒 Pharma Pro
Scabi-Mect Ivermectin 3 mg Tablet 20's 064840 PKR 668.48 PKR 33.42/tablet 🔒 Pharma Pro
Terbin Terbinafine 1 % Cream 10gm 026751 PKR 294.42 PKR 29.44/g 🔒 Pharma Pro
Terbin Terbinafine 1% Cream 5gm 026751 PKR 147.21 PKR 29.44/g 🔒 Pharma Pro
Terbin Terbinafine 1 % Gel 10gm 084014 PKR 206.60 PKR 20.66/g 🔒 Pharma Pro
Z-X Permethrin 5% Lotion 60ml 067937 PKR 189.49 PKR 3.16/mL 🔒 Pharma Pro
Z-X Permethrin 5% Cream 30gm 084017 PKR 79.79 PKR 2.66/g 🔒 Pharma Pro
A to Z

All 14 Seatle brands in Pakistan

  • Aquazole Clotrimazole + Hydrocortisone · 1 % + 1 % cream, 1% + 1% cream
  • Benzex Benzoyl peroxide · 4% cream
  • Betamet Betamethasone valerate · 1 mg lotion
  • CYGNET Ciprofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Dowquin Levofloxacin · 250 mg tablet, 500 mg tablet
  • Doxybact Doxycycline · 100 mg tablet
  • Flozex Fluconazole · 150 mg capsule
  • Fratazid Ceftriaxone · 1 g injection, 1000 mg injection, 250 mg injection
  • Moxidow Moxifloxacin · 400 mg tablet
  • Orpase Cefixime · 100 mg/5 mL suspension, 200 mg tablet, 200 mg capsule
  • Orzit Azithromycin · 200 mg/5 mL suspension
  • Scabi-Mect Ivermectin · 3 mg tablet, 6 mg tablet
  • Terbin Terbinafine · 1 % cream, 1 % gel, 1% cream
  • Z-X Permethrin · 5% cream, 5% lotion
Questions

Seatle: common questions

How many products does Seatle have in Pakistan?

Seatle Private Limited has 37 registered medicine presentations in Pakistan, sold under 14 brands and covering 14 generic medicines.

What are the main brands of Seatle?

By number of registered strengths and packs, its largest brands are Orpase (Cefixime), Fratazid (Ceftriaxone), CYGNET (Ciprofloxacin), Terbin (Terbinafine) and Aquazole (Clotrimazole + Hydrocortisone). This is not a sales ranking.

Which therapy areas does Seatle cover?

The most products are in Anti-infectives (35) and Dermatology (2).

Where can I see Seatle medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Seatle Private Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/seatle-private-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9